Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GLUE | CDXS | CDXC | ||
| Company | Monte Rosa Therapeutics Inc | Codexis Inc | Chromadex Corp CS | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.44 | 5.07 | 5.31 | ||
| High | 7.14 | 5.48 | 5.55 | ||
| Low | 6.41 | 5.07 | 5.25 | ||
| Last | 6.93 | 5.28 | 5.49 | ||
| Change | +0.42 | +0.16 | +0.08 | ||
| % Change | +6.45% | +3.13% | +1.48% | ||
| Volume | 2,630,600 | 3,250,100 | 1,204,900 | ||
| 20-Day Average Volume | 1,822,090 | 875,295 | 750,945 | ||
| Previous Close | 6.51 | 5.12 | 5.41 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.60 | 5.08 | 6.75 | ||
| 20-Day Raw Stochastic | 17.15% | 55.06% | 8.81% | ||
| 20-Day Relative Strength | 43.40% | 61.94% | 41.80% | ||
| Weighted Alpha | -36.69 | +41.27 | +69.92 | ||
| Today's Opinion | 56% Buy | 100% Buy | 56% Buy | ||
| Previous Opinion | 40% Buy | 100% Buy | 56% Buy | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.33% since 12/13/24 | -4.52% since 12/13/24 | -10.29% since 12/13/24 | ||
| Low | 6.15 on 12/19/24 | 5.07 on 12/20/24 | 5.25 on 12/20/24 | ||
| High | 7.95 on 12/17/24 | 6.01 on 12/17/24 | 6.23 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | -17.11% since 11/20/24 | +21.94% since 11/20/24 | -26.80% since 11/20/24 | ||
| Low | 6.15 on 12/19/24 | 4.30 on 11/21/24 | 5.25 on 12/20/24 | ||
| High | 10.70 on 12/02/24 | 6.08 on 12/11/24 | 7.97 on 11/29/24 | ||
| 3-Month | |||||
| %Chg | +6.94% since 09/20/24 | +70.32% since 09/20/24 | +51.24% since 09/20/24 | ||
| Low | 4.59 on 10/09/24 | 2.83 on 09/25/24 | 3.18 on 10/10/24 | ||
| High | 12.40 on 10/28/24 | 6.08 on 12/11/24 | 7.97 on 11/29/24 | ||
| 6-Month | |||||
| %Chg | +94.66% since 06/20/24 | +87.90% since 06/20/24 | +102.58% since 06/20/24 | ||
| Low | 3.21 on 06/28/24 | 2.56 on 09/10/24 | 2.31 on 06/26/24 | ||
| High | 12.40 on 10/28/24 | 6.08 on 12/11/24 | 7.97 on 11/29/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 425,758 | 429,676 | 419,343 | ||
| Shares Outstanding, K | 61,437 | 81,378 | 76,383 | ||
| Annual Sales | 0 | 70,140,000 | 83,570,000 | ||
| Annual Net Income | -135,350,000 | -76,240,000 | -4,940,000 | ||
| Last Quarter Sales | 9,220,000 | 12,830,000 | 25,580,000 | ||
| Last Quarter Net Income | -23,860,000 | -20,640,000 | 1,880,000 | ||
| 60-Month Beta | 1.37 | 2.15 | 2.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.29 on 11/07/24 | -0.29 on 10/31/24 | 0.02 on 10/31/24 | ||
| Latest Earnings Date | 11/14/24 | 10/31/24 | 10/31/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 549.00 | ||